• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APYX MEDICAL CORPORATION RENUVION; ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APYX MEDICAL CORPORATION RENUVION; ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bruise/Contusion (1754); Necrosis (1971); Partial thickness (Second Degree) Burn (2694)
Event Date 05/27/2022
Event Type  Injury  
Event Description
I had 360 degree liposuction and renuvion skin tightening to my abdomen.Shortly after surgery unusual bruising pattern was noted on my abdomen which i alerted my surgeon about.Evaluation revealed an area of necrosis.I was sent to hyperbaric treatments.Over the course of 2 weeks the bruising evolved and the skin changed and began to work with what appeared to be 2nd degree burns.I am still healing from the procedure.Fda safety report id # (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RENUVION
Type of Device
ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES
Manufacturer (Section D)
APYX MEDICAL CORPORATION
MDR Report Key14946656
MDR Text Key295498190
Report NumberMW5110724
Device Sequence Number1
Product Code GEI
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 07/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/06/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Patient Sequence Number1
Treatment
TIROSINT; TRIAMTERENE/HCTZ; VALSARTAN
Patient Outcome(s) Required Intervention;
Patient Age48 YR
Patient SexFemale
Patient Weight77 KG
Patient EthnicityHispanic
-
-